← Jürgen C. Becker

Papers by Jürgen C. Becker

Page 4 · newest first

151. Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanismsEuropean Journal of Cancer · 2015
152. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guidelineEuropean Journal of Cancer · 2015
153. Pre-Vaccination Frequencies of Th17 Cells Correlate with Vaccine-Induced T-Cell Responses to Survivin-Derived Peptide EpitopesPLoS ONE · 2015
154. The prevalence of peri‐implant diseases for two‐piece implants with an internal tube‐in‐tube connection: a cross‐sectional analysis of 512 implantsClinical Oral Implants Research · 2015
155. Impaired gp100-Specific CD8+ T-Cell Responses in the Presence of Myeloid-Derived Suppressor Cells in a Spontaneous Mouse Melanoma ModelView · 2015
156. Clinical performance of two‐piece zirconia implants in the posterior mandible and maxilla: a prospective cohort study over 2 yearsClinical Oral Implants Research · 2015
157. Clinically significant responses achieved with romidepsin across disease compartments in patients with cutaneous T-cell lymphomaLeukemia & lymphoma/Leukemia and lymphoma · 2015
158. Aggressive primary cutaneous B‐cell lymphomas show increased Angiopoietin‐2‐induced angiogenesisExperimental Dermatology · 2015
159. Tryptophan 2,3-dioxygenase (TDO)-reactive T cells differ in their functional characteristics in health and cancerOncoImmunology · 2014
160. Downregulation of MHC-I Expression Is Prevalent but Reversible in Merkel Cell CarcinomaCancer Immunology Research · 2014
161. Presence of Human Polyomavirus 6 in Mutation-Specific BRAF Inhibitor–Induced Epithelial ProliferationsJAMA Dermatology · 2014
162. Fluorescencein situhybridization and qPCR to detect Merkel cell polyomavirus physical status and load in Merkel cell carcinomasInternational Journal of Cancer · 2014
163. Somatostatin receptor expression in Merkel cell carcinoma as target for molecular imagingBMC Cancer · 2014
164. Intralesional Treatment of Stage III Metastatic Melanoma Patients with L19–IL2 Results in Sustained Clinical and Systemic Immunologic ResponsesCancer Immunology Research · 2014
165. The HSP70 Modulator MAL3-101 Inhibits Merkel Cell CarcinomaPLoS ONE · 2014
166. Telomerase reverse transcriptase promoter mutations in primary cutaneous melanomaNature Communications · 2014
167. T-cell Responses to Oncogenic Merkel Cell Polyomavirus Proteins Distinguish Patients with Merkel Cell Carcinoma from Healthy DonorsClinical Cancer Research · 2014
168. p53 Regulation by TRP2 Is Not Pervasive in MelanomaPLoS ONE · 2014
169. Merkel Cell Carcinoma: Epidemiology, Target, and TherapyCurrent Dermatology Reports · 2014
170. Neoadjuvant Imatinib in Advanced Primary or Locally Recurrent Dermatofibrosarcoma Protuberans: A Multicenter Phase II DeCOG Trial with Long-term Follow-upClinical Cancer Research · 2013
171. Concept and first experimental results of a new ferromagnetic assist device for extra-aortic counterpulsationInteractive Cardiovascular and Thoracic Surgery · 2013
172. Four‐year follow‐up of combined surgical therapy of advanced peri‐implantitis evaluating two methods of surface decontaminationJournal Of Clinical Periodontology · 2013
173. Impact of implant–abutment connection and positioning of the machined collar/microgap on crestal bone level changes: a systematic reviewClinical Oral Implants Research · 2013
174. Treatment of advanced cutaneous T‐cell lymphomas with non‐pegylated liposomal doxorubicin – Consensus of the lymphoma group of the Working Group Dermatologic OncologyJDDG Journal der Deutschen Dermatologischen Gesellschaft · 2013
175. Survivin in Adrenocortical Tumors - Pathophysiological Implications and Therapeutic PotentialHormone and Metabolic Research · 2012
176. Prospective International Multicenter Phase II Trial of Intravenous Pegylated Liposomal Doxorubicin Monochemotherapy in Patients With Stage IIB, IVA, or IVB Advanced Mycosis Fungoides: Final Results From EORTC 21012Journal of Clinical Oncology · 2012
177. Vascular endothelial growth factor receptor-3 expression in mycosis fungoidesLeukemia & lymphoma/Leukemia and lymphoma · 2012
178. BRAF mutation analysis of only one metastatic lesion can restrict the treatment of melanoma: a case reportBritish Journal of Dermatology · 2012
179. Improved Survival with MEK Inhibition in BRAF-Mutated MelanomaNew England Journal of Medicine · 2012
180. Cellular and cytokine-dependent immunosuppressive mechanisms of grm1-transgenic murine melanomaCancer Immunology Immunotherapy · 2012
181. Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanomaCancer Immunology Immunotherapy · 2012
182. Type I and II IFNs Inhibit Merkel Cell Carcinoma via Modulation of the Merkel Cell Polyomavirus T AntigensCancer Research · 2012
183. Combined surgical therapy of peri‐implantitis evaluating two methods of surface debridement and decontamination. A two‐year clinical follow up reportJournal Of Clinical Periodontology · 2012
184. P‐cadherin expression in Merkel cell carcinomas is associated with prolonged recurrence‐free survivalBritish Journal of Dermatology · 2012
185. Merkel cell carcinomaCurrent Opinion in Oncology · 2012
186. An Improved Search for the Neutron Electric Dipole Moment2011
187. Merkel cell carcinoma – pathogenesis, clinical aspects and treatmentJournal of the European Academy of Dermatology and Venereology · 2011
188. Impact of the outcome of guided bone regeneration in dehiscence‐type defects on the long‐term stability of peri‐implant health: clinical observations at 4 yearsClinical Oral Implants Research · 2011
189. High-Level Expression of Wild-Type p53 in Melanoma Cells is Frequently Associated with Inactivity in p53 Reporter Gene AssaysPLoS ONE · 2011
190. An intact retinoblastoma protein‐binding site in Merkel cell polyomavirus large T antigen is required for promoting growth of Merkel cell carcinoma cellsInternational Journal of Cancer · 2011
191. Impact of the method of surface debridement and decontamination on the clinical outcome following combined surgical therapy of peri-implantitis: a randomized controlled clinical studyJournal Of Clinical Periodontology · 2011
192. Homo‐ and heterotypic cell–cell contacts in Merkel cells and Merkel cell carcinomas: heterogeneity and indications for cadherin switchingHistopathology · 2011
193. Management of cutaneous side effects of EGFR inhibitors: recommendations from a German expert panel for the primary treating physicianJDDG Journal der Deutschen Dermatologischen Gesellschaft · 2010
194. Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell LymphomaJournal of Clinical Oncology · 2010
195. A novel xenograft model of cutaneous T‐cell lymphomaExperimental Dermatology · 2010
196. A prospective, randomized pilot study on the safety and efficacy of recombinant human growth and differentiation factor‐5 coated onto β‐tricalcium phosphate for sinus lift augmentationClinical Oral Implants Research · 2010
197. Merkel Cell Polyomavirus-Infected Merkel Cell Carcinoma Cells Require Expression of Viral T AntigensJournal of Virology · 2010
198. Impact of defect configuration on the clinical outcome following surgical regenerative therapy of peri‐implantitisJournal Of Clinical Periodontology · 2010
199. Mycosis fungoides bullosa: a case report and review of the literatureJournal of Medical Case Reports · 2010
200. HPV DNA Detection in Tumours of the Head and Neck: A Comparative Light Microscopy and DNA Hybridization StudyORL · 2010